News archives

Alligator advances 4-1BB immuno-oncology antibody ATOR-1017 to pre-clinical development

Yes
Lund, Sweden – Alligator Bioscience AB (Nasdaq Stockholm; ATORX), a biotechnology company developing antibody-based pharmaceuticals for cancer treatment, today announced
Läs Mer

Alligator Bioscience presents promising immuno-oncology data at US conference; – Strong new preclinical findings for ADC-1013 and ATOR-1015

Yes
Lund, Sweden – Alligator Bioscience AB (Nasdaq Stockholm; ATORX) today presented new pre-clinical data on the CD40 agonistic immuno-oncology antibody,
Läs Mer

Bulletin from the annual shareholders’ meeting in Alligator Bioscience AB (publ) on May 2, 2017

Yes
Today, on May 2, 2017, an annual shareholders’ meeting was held in Alligator Bioscience AB. A summary of the resolutions
Läs Mer

Alligator Bioscience AB Interim report January-March 2017

Yes
Lund, Sweden – Alligator Bioscience AB (Nasdaq Stockholm; ATORX) today announced its report for the first quarter 2017. “In the
Läs Mer

Alligator Bioscience to present new pre-clinical data for ADC-1013 and ATOR-1015 at PEGS conference in Boston, May 4

No
Lund, Sweden – Alligator Bioscience AB (Nasdaq Stockholm; ATORX) announced today that it will present new pre-clinical data on the
Läs Mer

Change in number of shares and votes in Alligator Bioscience AB (publ)

Yes
Lund, Sweden - Alligator Bioscience AB (Nasdaq Stockholm; ATORX) announced today that the number of shares and votes in Alligator
Läs Mer

Alligator announces completion of first phase I study with CD40 agonistic immuno-oncology antibody ADC-1013

Yes
Lund, Sweden - Alligator Bioscience AB (Nasdaq Stockholm; ATORX) announced today that the first phase I study with ADC-1013, a
Läs Mer

Alligator Bioscience Annual Report for 2016 published

Yes
Lund, Sweden - Alligator Bioscience AB (Nasdaq Stockholm; ATORX) today announces that that the Swedish version of Annual Report for
Läs Mer

Notice of annual shareholders’ meeting in Alligator Bioscience AB (publ)

Yes
The shareholders of Alligator Bioscience AB, Reg. No 556597-8201, are hereby invited to attend the annual shareholders’ meeting to be
Läs Mer